Gossamer Bio (GOSS) vs Xilio Therapeutics (XLO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Xilio Therapeutics (XLO) has outperformed Gossamer Bio (GOSS) over the past year, losing 21.7% versus a loss of 94.9%. Gossamer Bio is the larger company by market cap ($60.4 million vs $59.3 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GOSS | XLO |
|---|---|---|
| Share price | $9.88 | $9.01 |
| Market cap | $60.43M | $59.29M |
| 1-day change | -2.95% | 0.00% |
| YTD return | -95.90% | +0.56% |
| 1-year return | -94.91% | -21.71% |
| 5-year return | -99.10% | — |
| EPS (TTM) | $-52.80 | $-0.60 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $309.60 | $12.59 |
| 52-week low | $9.12 | $6.47 |
| Distance from 52-week high | -96.81% | -28.41% |
| Average volume | 377.00K | 19.05K |
| Shares outstanding | 6.12M | 6.58M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- XLO has outperformed GOSS by 73.2 percentage points over the past year.
GOSS vs XLO FAQ
Which is bigger, Gossamer Bio or Xilio Therapeutics?
Gossamer Bio (GOSS) is larger, with a market capitalization of $60.43M compared with $59.29M for Xilio Therapeutics (XLO).
Which stock has performed better over the past year, GOSS or XLO?
XLO returned -21.71% over the past 12 months, compared with -94.91% for GOSS (price return, excluding dividends). Past performance does not predict future results.
Are Gossamer Bio and Xilio Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.